IMARC Group, a leading market research company, has recently releases report titled “Peripheral Artery Disease Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global Peripheral Artery Disease market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How Big Is The Peripheral Artery Disease Market?
The global peripheral artery disease market size reached US$ 4.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.94% during 2023-2028.
What are Peripheral Artery Disease?
Peripheral artery disease (PAD) represents a cardiovascular disorder in which constricted arteries restrict blood flow to the limbs. It results in leg numbness, feet or toe sores, hair loss, painful cramps in hips and thighs, coldness and weak pulse, erectile dysfunction among men, etc. PAD is caused when a plaque, also known as atherosclerosis, develops in leg arteries that carry nutrient-rich blood and oxygen through the heart to the arms and legs. It is diagnosed using various techniques, such as ultrasound scan, angiography, blood tests, the ankle-brachial index, Doppler and ultrasound (duplex) imaging, magnetic resonance angiography (MRA), computed tomographic angiography (CT), etc
What Are The Growth Prospects And Trends In The Peripheral Artery Disease Industry?
The changing lifestyles of individuals, the rising adoption of unhealthy dietary patterns, alcoholism, and obesity, on account of the lack of physical activities, are among the primary factors driving the peripheral artery disease market. Besides this, the emerging trend of minimally invasive surgeries (MIS), owing to less postoperative pain, fewer operative and major complications, shortened hospital stay, faster recovery times, and less stress on the immune system, is further augmenting the market growth.
Moreover, the launch of several policies by the government bodies to promote and spread awareness in individuals towards the benefits of PAD devices is also catalyzing the global market. Apart from this, the escalating prevalence of cardiac illnesses, especially among the geriatric population and the expanding healthcare industry, are acting as significant growth-inducing factors. Furthermore, the rising focus of the leading players on mergers and acquisitions (MA) to develop effective treatment options is anticipated to propel the peripheral artery disease market over the forecasted period
What Is Included In Market Segmentation?
The report has segmented the market into the following categories:
Breakup by Type:
- Peripheral Angioplasty Balloons
- Peripheral Stents
- Peripheral Catheters
- Inferior Vena Cava (IVC) Filters
- Plaque Modification Devices
- Hemodynamic Flow Alteration Devices
- Peripheral Accessories
Breakup by End User:
- Hospitals
- Specialty Clinics
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Who Are The Key Players Operating In The Industry?
The report covers the major market players including:
- Abbott Laboratories
- AngioDynamics
- Braun Melsungen AG
- Becton Dickinson and Company
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Cardinal Health Inc.
- Cook Medical LLC
- Koninklijke Philips N.V.
- Medtronic plc
- and Terumo Corporation.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: [email protected]
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
Peripheral Artery Disease Market: Information By Treatment Type (Devices (Angioplasty Balloon, Angioplasty Stents (Stenting), Catheters, Plaque Modification Devices (Atherectomy), Hemodynamic Flow Alteration Devices, Others), Drugs (Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs)) End User (Hospitals and Clinics, Ambulatory Surgery Centers) - Forecast till 2027Increased global prevalence of artery diseases has fuelled the demand for peripheral artery disease market.
Market Research Future (MRFR) in its latest report reveals that the global peripheral artery diseases market will exhibit a healthy CAGR during between 2017 and 2023.Atherosclerosis in the peripheral arteries remain the leading cause of peripheral artery disease.
Atherosclerosis in associated with hardening of plaque that trigger clot formation in arteries, leading to their blockage.Global demand for peripheral artery disease treatment has grown substantially in recent years.
Availability of superior treatment and therapeutics for peripheral artery disease has reflected favourably on the market.
Many market players have ramped up investment in R program to develop innovative treatment solution.
Data released by European Federation of Pharmaceutical Industries and Association reveals that in 2016 R investments in the Pharmaceutical Industry reached EUR 35000 Mn.
At an estimated value of over USD 4.53 billion in 2019, the Global Peripheral Artery Disease Market is predicted to thrive at a CAGR of 6.2% and valued at over USD 8.78 billion over the forecast year 2020-2030.Peripheral artery disease is a common circulatory problem that causes narrowing of the peripheral arteries.
Generally, it affects arteries in the legs and sometimes affect the arteries carrying blood from heart to arms, kidneys, head, and stomach.
It is mainly caused by the deposition of fats or plaques in the artery walls.
The exercise, tobacco cessation, and a healthy diet are the main treatments for this disease; however, when such treatments aren't enough, medication or surgery can be helpful.Access Full Description of this report at:- https://www.nextmsc.com/report/peripheral-artery-disease-market Top Companies: Abbott Laboratories, Boston Scientific Corporation, Cardinal Health, Inc., Terumo Corporation, Cook Medical, Becton, Dickinson and Company, Koninklijke Philips N.V, AngioDynamics, Inc., Biotronik and others.The global peripheral artery disease market share is segmented on the basis of type, and geography.
On the basis of type, the market is segmented into peripheral angioplasty balloons, peripheral catheters, inferior vena cava (IVC) filters, peripheral stents, plaque modification devices, hemodynamic flow alteration devices, and peripheral accessories.
Geographic fragmentation and analysis of each segment includes regions comprising North America, Europe, Asia Pacific and RoW.Request sample copy of this report at:- https://www.nextmsc.com/peripheral-artery-disease-market/request-sample In terms of geography, North America held major share of the market in 2019.
